Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Profound Medical Corp (NQ: PROF )

8.750 +0.090 (+1.04%)
Streaming Delayed Price Updated: 1:09 PM EDT, Jul 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,060
Open 8.740
Bid (Size) 8.650 (7)
Ask (Size) 8.850 (6)
Prev. Close 8.660
Today's Range 8.610 - 8.850
52wk Range 7.110 - 13.46
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Profound Medical Annual General Meeting of Shareholders Voting Results
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan
From Profound Medical Corp.
Via GlobeNewswire

Performance

YTD
+10.06%
+10.06%
1 Month
+20.69%
+20.69%
3 Month
+6.58%
+6.58%
6 Month
+19.86%
+19.86%
1 Year
-34.06%
-34.06%

More News

Read More
PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical: Q4 Earnings Insights
Via Benzinga
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
From Profound Medical Corp.
Via GlobeNewswire
PROF Stock Earnings: Profound Medical Misses EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Earnings Scheduled For March 7, 2024
Via Benzinga
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Non-Brokered Private Placement
From Profound Medical Corp.
Via GlobeNewswire
BioMedNewsBreaks – Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) Announces Pricing of US$20M Public Offering
Via Investor Brand Network
Exposures Product Safety
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
From Profound Medical Corp.
Via GlobeNewswire
Chord Energy, Profound Medical And 3 Stocks To Watch Heading Into Thursday
Via Benzinga
Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Proposed Public Offering of Common Shares
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in the Stifel 2023 Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Third Quarter 2023 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical 2023 Virtual Analyst & Investor Day Agenda
From Profound Medical Corp.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.